Internal Medicine, Rheumatology · Duncansville, PA
NPI
1639162241
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
175 Meadowbrook Ln
Duncansville, PA, 16635
Phone (814) 693-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$879K
81,519 services
Medicare patients, 2024
505
Average age 71
Drug cost, 2024
$2.4M
5,657 prescriptions
Company payments, 2025
$3,273
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lori A Lavelle was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 40,000 times for 20 patients. In total Lori A Lavelle billed 81,519 services in 110 codes, and Medicare paid $879K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 40,000 | 20 | $3.63 | $145K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,300 | 28 | $0.10 | $227 |
| J0897 Injection, denosumab, 1 mg | Office | 1,500 | 17 | $20.51 | $31K |
| 99214 Office E&M - Established | Office | 734 | 420 | $85.29 | $63K |
| 36415 Venipuncture Blood Collection | Office | 470 | 302 | $8.61 | $4,048 |
| 85025 Blood Count | Office | 468 | 295 | $7.50 | $3,509 |
| 85651 Clinical Chemistry | Office | 444 | 279 | $4.12 | $1,831 |
| 86140 Clinical Chemistry | Office | 389 | 251 | $5.06 | $1,966 |
| 82565 Clinical Chemistry | Office | 355 | 221 | $4.96 | $1,762 |
| 84460 Clinical Chemistry | Office | 351 | 220 | $5.12 | $1,796 |
| 84450 Clinical Chemistry | Office | 350 | 219 | $5.02 | $1,758 |
| 86235 Immunoassay | Office | 308 | 53 | $17.26 | $5,317 |
| 96401 Chemotherapy Administration | Office | 184 | 20 | $48.88 | $8,994 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 169 | 130 | $11.59 | $1,959 |
| 96413 Chemotherapy Administration | Office | 143 | 47 | $90.75 | $13K |
By year: 2022 $776K for 73,524 services; 2023 $698K for 80,415 services; 2024 $879K for 81,519 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 470 | 302 | $8.61 | $4,048 |
| 85025 Blood Count | 468 | 295 | $7.50 | $3,509 |
| 85651 Clinical Chemistry | 444 | 279 | $4.12 | $1,831 |
| 86140 Clinical Chemistry | 389 | 251 | $5.06 | $1,966 |
| 82565 Clinical Chemistry | 355 | 221 | $4.96 | $1,762 |
| 84460 Clinical Chemistry | 351 | 220 | $5.12 | $1,796 |
| 84450 Clinical Chemistry | 350 | 219 | $5.02 | $1,758 |
| 86235 Immunoassay | 308 | 53 | $17.26 | $5,317 |
| 80053 Clinical Chemistry | 135 | 125 | $10.28 | $1,388 |
| 86225 Immunoassay | 98 | 80 | $13.35 | $1,308 |
Medicare prescription drug claims, 2024
In 2024, the drug Lori A Lavelle prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 715 prescriptions and refills. In total Lori A Lavelle wrote 5,657 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 715 | 1,633 | 294 | $32K |
| Methotrexate Methotrexate Sodium | 379 | 792 | 148 | $11K |
| Leflunomide Generic | 359 | 714 | 154 | $20K |
| Methylprednisolone Generic | 310 | 461 | 186 | $4,573 |
| Sulfasalazine Generic | 261 | 540 | 111 | $5,027 |
| Tramadol Hcl Generic | 258 | 285 | 58 | $2,354 |
| Meloxicam Generic | 223 | 516 | 108 | $1,135 |
| Gabapentin Generic | 199 | 426 | 89 | $3,169 |
| Prednisone Generic | 193 | 339 | 91 | $1,260 |
| Pregabalin Generic | 160 | 224 | 37 | $2,655 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 145 | 145 | 22 | $3,166 |
| Duloxetine Hcl Generic | 136 | 297 | 48 | $2,943 |
| Zolpidem Tartrate Generic | 104 | 132 | 16 | $383 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 103 | 103 | 33 | $1,246 |
| Allopurinol Generic | 98 | 221 | 33 | $1,198 |
Brand drugs: 634 claims; generic drugs: 5,023 claims; opioid claims: 584.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori A Lavelle $3,273 ($3,273 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $1,514.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 172 | $1,514 |
| Amgen Inc. AMGN | 30 | $585 |
| Pfizer Inc. PFE | 37 | $293 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $204 |
| GlaxoSmithKline, LLC. GSK | 13 | $200 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $159 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $94.89 |
| Bioventus LLC BVS | 1 | $47.63 |
| Kyowa Kirin, Inc. 4151.T | 1 | $29.89 |
| Lilly USA, LLC LLY | 1 | $22.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.